nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—asthma—chronic obstructive pulmonary disease	0.294	1	CtDrD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.179	0.514	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisone—chronic obstructive pulmonary disease	0.169	0.486	CiPCiCtD
Fluticasone Propionate—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.0449	0.353	CbGbCtD
Fluticasone Propionate—SERPINA6—Prednisolone—chronic obstructive pulmonary disease	0.0317	0.249	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0148	0.117	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.014	0.11	CbGbCtD
Fluticasone Propionate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00613	0.0482	CbGbCtD
Fluticasone Propionate—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.00519	0.0312	CrCrCtD
Fluticasone Propionate—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00506	0.0304	CrCrCtD
Fluticasone Propionate—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00506	0.0304	CrCrCtD
Fluticasone Propionate—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00506	0.0304	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.00504	0.0303	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00492	0.0295	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.0049	0.0294	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00478	0.0287	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00478	0.0287	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00477	0.0286	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00465	0.028	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00464	0.0279	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00464	0.0279	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00464	0.0279	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00453	0.0272	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00453	0.0272	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00453	0.0272	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00453	0.0272	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00442	0.0265	CrCrCtD
Fluticasone Propionate—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00442	0.0265	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00431	0.0259	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00431	0.0259	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00431	0.0259	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00431	0.0259	CrCrCtD
Fluticasone Propionate—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00431	0.0259	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00421	0.0253	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00421	0.0253	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00421	0.0253	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00421	0.0253	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00421	0.0253	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00421	0.0253	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00421	0.0253	CrCrCtD
Fluticasone Propionate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00414	0.0326	CbGbCtD
Fluticasone Propionate—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00411	0.0247	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00411	0.0247	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00411	0.0247	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00403	0.0242	CrCrCtD
Fluticasone Propionate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00395	0.0311	CbGbCtD
Fluticasone Propionate—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00394	0.0236	CrCrCtD
Fluticasone Propionate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00352	0.0277	CbGbCtD
Fluticasone Propionate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.0163	CbGbCtD
Fluticasone Propionate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00195	0.0154	CbGbCtD
Fluticasone Propionate—PLA2G4A—respiratory system—chronic obstructive pulmonary disease	0.000393	0.0687	CbGeAlD
Fluticasone Propionate—SERPINA6—respiratory system—chronic obstructive pulmonary disease	0.000391	0.0684	CbGeAlD
Fluticasone Propionate—PLA2G4A—connective tissue—chronic obstructive pulmonary disease	0.000346	0.0604	CbGeAlD
Fluticasone Propionate—PLA2G4A—bronchus—chronic obstructive pulmonary disease	0.000323	0.0565	CbGeAlD
Fluticasone Propionate—PLA2G4A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000316	0.0553	CbGeAlD
Fluticasone Propionate—PGR—respiratory system—chronic obstructive pulmonary disease	0.000297	0.0519	CbGeAlD
Fluticasone Propionate—PLA2G4A—trachea—chronic obstructive pulmonary disease	0.00029	0.0507	CbGeAlD
Fluticasone Propionate—NR3C2—connective tissue—chronic obstructive pulmonary disease	0.000281	0.0491	CbGeAlD
Fluticasone Propionate—NR3C2—bronchus—chronic obstructive pulmonary disease	0.000263	0.046	CbGeAlD
Fluticasone Propionate—PGR—connective tissue—chronic obstructive pulmonary disease	0.000261	0.0457	CbGeAlD
Fluticasone Propionate—NR3C2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000257	0.045	CbGeAlD
Fluticasone Propionate—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000239	0.0418	CbGeAlD
Fluticasone Propionate—NR3C2—trachea—chronic obstructive pulmonary disease	0.000236	0.0413	CbGeAlD
Fluticasone Propionate—PLA2G4A—lung—chronic obstructive pulmonary disease	0.000209	0.0365	CbGeAlD
Fluticasone Propionate—SERPINA6—lung—chronic obstructive pulmonary disease	0.000208	0.0363	CbGeAlD
Fluticasone Propionate—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000173	0.0302	CbGeAlD
Fluticasone Propionate—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000171	0.0299	CbGeAlD
Fluticasone Propionate—NR3C2—lung—chronic obstructive pulmonary disease	0.00017	0.0296	CbGeAlD
Fluticasone Propionate—PGR—lung—chronic obstructive pulmonary disease	0.000158	0.0276	CbGeAlD
Fluticasone Propionate—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000151	0.0264	CbGeAlD
Fluticasone Propionate—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000141	0.0246	CbGeAlD
Fluticasone Propionate—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000138	0.0241	CbGeAlD
Fluticasone Propionate—NR3C1—trachea—chronic obstructive pulmonary disease	0.000127	0.0221	CbGeAlD
Fluticasone Propionate—CYP3A5—lung—chronic obstructive pulmonary disease	9.17e-05	0.016	CbGeAlD
Fluticasone Propionate—NR3C1—lung—chronic obstructive pulmonary disease	9.1e-05	0.0159	CbGeAlD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.253	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.253	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	8.84e-05	0.247	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	8.84e-05	0.247	CbGdCrCtD
Fluticasone Propionate—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	8.51e-05	0.317	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	8.21e-05	0.306	CrCbGaD
Fluticasone Propionate—Dexamethasone—NOS2—chronic obstructive pulmonary disease	6.94e-05	0.259	CrCbGaD
Fluticasone Propionate—Infection—Tiotropium—chronic obstructive pulmonary disease	6.12e-05	0.00122	CcSEcCtD
Fluticasone Propionate—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	6.09e-05	0.00121	CcSEcCtD
Fluticasone Propionate—Malnutrition—Formoterol—chronic obstructive pulmonary disease	6.09e-05	0.00121	CcSEcCtD
Fluticasone Propionate—Viral infection—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.00121	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	6.04e-05	0.0012	CcSEcCtD
Fluticasone Propionate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	6.01e-05	0.0012	CcSEcCtD
Fluticasone Propionate—Mental disorder—Montelukast—chronic obstructive pulmonary disease	6e-05	0.0012	CcSEcCtD
Fluticasone Propionate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	5.98e-05	0.00119	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	5.97e-05	0.00119	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	5.95e-05	0.00119	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	5.9e-05	0.00118	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	5.85e-05	0.00117	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	5.85e-05	0.00117	CcSEcCtD
Fluticasone Propionate—Nausea—Roflumilast—chronic obstructive pulmonary disease	5.82e-05	0.00116	CcSEcCtD
Fluticasone Propionate—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	5.79e-05	0.00115	CcSEcCtD
Fluticasone Propionate—Cataract—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.00115	CcSEcCtD
Fluticasone Propionate—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	5.75e-05	0.00115	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	5.73e-05	0.00114	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	5.73e-05	0.00114	CcSEcCtD
Fluticasone Propionate—Tremor—Formoterol—chronic obstructive pulmonary disease	5.71e-05	0.00114	CcSEcCtD
Fluticasone Propionate—Tremor—Arformoterol—chronic obstructive pulmonary disease	5.71e-05	0.00114	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	5.66e-05	0.00113	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	5.65e-05	0.00113	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	5.65e-05	0.00113	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	5.61e-05	0.00112	CcSEcCtD
Fluticasone Propionate—Agitation—Arformoterol—chronic obstructive pulmonary disease	5.6e-05	0.00112	CcSEcCtD
Fluticasone Propionate—Agitation—Formoterol—chronic obstructive pulmonary disease	5.6e-05	0.00112	CcSEcCtD
Fluticasone Propionate—Tremor—Montelukast—chronic obstructive pulmonary disease	5.59e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	5.56e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Angioedema—Formoterol—chronic obstructive pulmonary disease	5.56e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	5.53e-05	0.0011	CcSEcCtD
Fluticasone Propionate—Malaise—Formoterol—chronic obstructive pulmonary disease	5.49e-05	0.00109	CcSEcCtD
Fluticasone Propionate—Malaise—Arformoterol—chronic obstructive pulmonary disease	5.49e-05	0.00109	CcSEcCtD
Fluticasone Propionate—Agitation—Montelukast—chronic obstructive pulmonary disease	5.48e-05	0.00109	CcSEcCtD
Fluticasone Propionate—Angioedema—Montelukast—chronic obstructive pulmonary disease	5.45e-05	0.00109	CcSEcCtD
Fluticasone Propionate—Tremor—Salbutamol—chronic obstructive pulmonary disease	5.39e-05	0.00107	CcSEcCtD
Fluticasone Propionate—Palpitations—Formoterol—chronic obstructive pulmonary disease	5.38e-05	0.00107	CcSEcCtD
Fluticasone Propionate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	5.38e-05	0.00107	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	5.34e-05	0.00106	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	5.33e-05	0.00106	CcSEcCtD
Fluticasone Propionate—Cough—Formoterol—chronic obstructive pulmonary disease	5.31e-05	0.00106	CcSEcCtD
Fluticasone Propionate—Cough—Arformoterol—chronic obstructive pulmonary disease	5.31e-05	0.00106	CcSEcCtD
Fluticasone Propionate—Agitation—Salbutamol—chronic obstructive pulmonary disease	5.28e-05	0.00105	CcSEcCtD
Fluticasone Propionate—Palpitations—Montelukast—chronic obstructive pulmonary disease	5.27e-05	0.00105	CcSEcCtD
Fluticasone Propionate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	5.26e-05	0.00105	CcSEcCtD
Fluticasone Propionate—Hypertension—Formoterol—chronic obstructive pulmonary disease	5.26e-05	0.00105	CcSEcCtD
Fluticasone Propionate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	5.25e-05	0.00105	CcSEcCtD
Fluticasone Propionate—Cough—Montelukast—chronic obstructive pulmonary disease	5.2e-05	0.00104	CcSEcCtD
Fluticasone Propionate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	5.19e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Malaise—Salbutamol—chronic obstructive pulmonary disease	5.19e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	5.18e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Chest pain—Formoterol—chronic obstructive pulmonary disease	5.18e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	5.18e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	5.18e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Anxiety—Formoterol—chronic obstructive pulmonary disease	5.17e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	5.17e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	5.16e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	5.16e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	5.15e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	5.15e-05	0.00103	CcSEcCtD
Fluticasone Propionate—Discomfort—Formoterol—chronic obstructive pulmonary disease	5.12e-05	0.00102	CcSEcCtD
Fluticasone Propionate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	5.12e-05	0.00102	CcSEcCtD
Fluticasone Propionate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	5.08e-05	0.00101	CcSEcCtD
Fluticasone Propionate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	5.08e-05	0.00101	CcSEcCtD
Fluticasone Propionate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	5.07e-05	0.00101	CcSEcCtD
Fluticasone Propionate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	5.07e-05	0.00101	CcSEcCtD
Fluticasone Propionate—Anxiety—Montelukast—chronic obstructive pulmonary disease	5.06e-05	0.00101	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	5.04e-05	0.00101	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	5.04e-05	0.001	CcSEcCtD
Fluticasone Propionate—Cough—Salbutamol—chronic obstructive pulmonary disease	5.02e-05	0.001	CcSEcCtD
Fluticasone Propionate—Oedema—Arformoterol—chronic obstructive pulmonary disease	4.97e-05	0.000991	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	4.97e-05	0.000991	CcSEcCtD
Fluticasone Propionate—Oedema—Formoterol—chronic obstructive pulmonary disease	4.97e-05	0.000991	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	4.97e-05	0.000991	CcSEcCtD
Fluticasone Propionate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	4.96e-05	0.00099	CcSEcCtD
Fluticasone Propionate—Infection—Formoterol—chronic obstructive pulmonary disease	4.94e-05	0.000984	CcSEcCtD
Fluticasone Propionate—Infection—Arformoterol—chronic obstructive pulmonary disease	4.94e-05	0.000984	CcSEcCtD
Fluticasone Propionate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	4.9e-05	0.000976	CcSEcCtD
Fluticasone Propionate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	4.9e-05	0.000976	CcSEcCtD
Fluticasone Propionate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	4.89e-05	0.000975	CcSEcCtD
Fluticasone Propionate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	4.88e-05	0.000973	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	4.87e-05	0.000972	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	4.87e-05	0.000972	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	4.87e-05	0.000971	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	4.87e-05	0.000971	CcSEcCtD
Fluticasone Propionate—Oedema—Montelukast—chronic obstructive pulmonary disease	4.87e-05	0.000971	CcSEcCtD
Fluticasone Propionate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	4.85e-05	0.000967	CcSEcCtD
Fluticasone Propionate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	4.85e-05	0.000967	CcSEcCtD
Fluticasone Propionate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	4.84e-05	0.000964	CcSEcCtD
Fluticasone Propionate—Infection—Montelukast—chronic obstructive pulmonary disease	4.84e-05	0.000964	CcSEcCtD
Fluticasone Propionate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	4.83e-05	0.000962	CcSEcCtD
Fluticasone Propionate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	4.83e-05	0.000962	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	4.81e-05	0.000959	CcSEcCtD
Fluticasone Propionate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	4.79e-05	0.000955	CcSEcCtD
Fluticasone Propionate—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000953	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	4.77e-05	0.000952	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	4.76e-05	0.00095	CcSEcCtD
Fluticasone Propionate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	4.73e-05	0.000943	CcSEcCtD
Fluticasone Propionate—Oedema—Salbutamol—chronic obstructive pulmonary disease	4.69e-05	0.000936	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	4.69e-05	0.000936	CcSEcCtD
Fluticasone Propionate—Infection—Salbutamol—chronic obstructive pulmonary disease	4.66e-05	0.00093	CcSEcCtD
Fluticasone Propionate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	4.62e-05	0.000921	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	4.6e-05	0.000918	CcSEcCtD
Fluticasone Propionate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	4.58e-05	0.000913	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000912	CcSEcCtD
Fluticasone Propionate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	4.56e-05	0.000909	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	4.54e-05	0.000905	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	4.53e-05	0.000903	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	4.53e-05	0.000903	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	4.47e-05	0.000891	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	4.43e-05	0.000884	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	4.43e-05	0.000883	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	4.43e-05	0.000883	CcSEcCtD
Fluticasone Propionate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	4.36e-05	0.000869	CcSEcCtD
Fluticasone Propionate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	4.32e-05	0.000861	CcSEcCtD
Fluticasone Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	4.29e-05	0.00506	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.28e-05	0.00505	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	4.28e-05	0.000852	CcSEcCtD
Fluticasone Propionate—Pain—Arformoterol—chronic obstructive pulmonary disease	4.25e-05	0.000847	CcSEcCtD
Fluticasone Propionate—Pain—Formoterol—chronic obstructive pulmonary disease	4.25e-05	0.000847	CcSEcCtD
Fluticasone Propionate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.00497	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.19e-05	0.00494	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	4.18e-05	0.000834	CcSEcCtD
Fluticasone Propionate—Pain—Montelukast—chronic obstructive pulmonary disease	4.16e-05	0.00083	CcSEcCtD
Fluticasone Propionate—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.15e-05	0.0049	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	4.15e-05	0.000828	CcSEcCtD
Fluticasone Propionate—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.13e-05	0.00488	CbGpPWpGaD
Fluticasone Propionate—Rash—Aminophylline—chronic obstructive pulmonary disease	4.12e-05	0.000821	CcSEcCtD
Fluticasone Propionate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	4.11e-05	0.00082	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	4.1e-05	0.000818	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	4.1e-05	0.000817	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	4.1e-05	0.000817	CcSEcCtD
Fluticasone Propionate—Headache—Aminophylline—chronic obstructive pulmonary disease	4.09e-05	0.000816	CcSEcCtD
Fluticasone Propionate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	4.07e-05	0.00481	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	4.07e-05	0.000812	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	4.06e-05	0.00081	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	4.06e-05	0.00081	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	4.03e-05	0.00476	CbGpPWpGaD
Fluticasone Propionate—Pain—Salbutamol—chronic obstructive pulmonary disease	4.01e-05	0.0008	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	3.99e-05	0.0047	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	3.98e-05	0.000794	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	3.96e-05	0.00467	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Formoterol—chronic obstructive pulmonary disease	3.95e-05	0.000787	CcSEcCtD
Fluticasone Propionate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	3.95e-05	0.000787	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	3.93e-05	0.000783	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	3.93e-05	0.000783	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	3.93e-05	0.000783	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	3.93e-05	0.000783	CcSEcCtD
Fluticasone Propionate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	3.92e-05	0.000781	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	3.91e-05	0.00462	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	3.91e-05	0.00461	CbGpPWpGaD
Fluticasone Propionate—Rash—Tiotropium—chronic obstructive pulmonary disease	3.88e-05	0.000774	CcSEcCtD
Fluticasone Propionate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	3.88e-05	0.000773	CcSEcCtD
Fluticasone Propionate—Nausea—Aminophylline—chronic obstructive pulmonary disease	3.88e-05	0.000773	CcSEcCtD
Fluticasone Propionate—Urticaria—Montelukast—chronic obstructive pulmonary disease	3.87e-05	0.000771	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	3.87e-05	0.000771	CcSEcCtD
Fluticasone Propionate—Headache—Tiotropium—chronic obstructive pulmonary disease	3.86e-05	0.000769	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	3.85e-05	0.000767	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	3.85e-05	0.000767	CcSEcCtD
Fluticasone Propionate—Face oedema—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.000766	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	3.84e-05	0.000765	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	3.83e-05	0.00452	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	3.81e-05	0.0045	CbGpPWpGaD
Fluticasone Propionate—Irritability—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000757	CcSEcCtD
Fluticasone Propionate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	3.73e-05	0.000743	CcSEcCtD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	3.72e-05	0.00439	CbGpPWpGaD
Fluticasone Propionate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	3.71e-05	0.00074	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	3.71e-05	0.00074	CcSEcCtD
Fluticasone Propionate—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.71e-05	0.00437	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	3.66e-05	0.00073	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	3.66e-05	0.00073	CcSEcCtD
Fluticasone Propionate—Nausea—Tiotropium—chronic obstructive pulmonary disease	3.66e-05	0.000729	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	3.64e-05	0.00429	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	3.59e-05	0.000715	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	3.57e-05	0.00421	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	3.55e-05	0.00418	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	3.52e-05	0.000701	CcSEcCtD
Fluticasone Propionate—Pruritus—Formoterol—chronic obstructive pulmonary disease	3.52e-05	0.000701	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.00069	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	3.46e-05	0.000689	CcSEcCtD
Fluticasone Propionate—Pruritus—Montelukast—chronic obstructive pulmonary disease	3.44e-05	0.000687	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	3.42e-05	0.00403	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.41e-05	0.00403	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	3.41e-05	0.00402	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	3.41e-05	0.00402	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	3.4e-05	0.000678	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	3.4e-05	0.000678	CcSEcCtD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.39e-05	0.00401	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	3.39e-05	0.004	CbGpPWpGaD
Fluticasone Propionate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	3.38e-05	0.000675	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	3.36e-05	0.00396	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	3.33e-05	0.000664	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	3.33e-05	0.00393	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	3.32e-05	0.000662	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	3.3e-05	0.0039	CbGpPWpGaD
Fluticasone Propionate—Erythema—Prednisolone—chronic obstructive pulmonary disease	3.3e-05	0.000658	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	3.29e-05	0.00388	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	3.29e-05	0.000655	CcSEcCtD
Fluticasone Propionate—Dizziness—Formoterol—chronic obstructive pulmonary disease	3.29e-05	0.000655	CcSEcCtD
Fluticasone Propionate—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.28e-05	0.00387	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Montelukast—chronic obstructive pulmonary disease	3.22e-05	0.000642	CcSEcCtD
Fluticasone Propionate—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	3.22e-05	0.0038	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	3.21e-05	0.00064	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.119	CrCbGaD
Fluticasone Propionate—PLA2G4A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	3.18e-05	0.00376	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Formoterol—chronic obstructive pulmonary disease	3.16e-05	0.00063	CcSEcCtD
Fluticasone Propionate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	3.16e-05	0.00063	CcSEcCtD
Fluticasone Propionate—Rash—Arformoterol—chronic obstructive pulmonary disease	3.13e-05	0.000625	CcSEcCtD
Fluticasone Propionate—Rash—Formoterol—chronic obstructive pulmonary disease	3.13e-05	0.000625	CcSEcCtD
Fluticasone Propionate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	3.13e-05	0.000624	CcSEcCtD
Fluticasone Propionate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	3.13e-05	0.000624	CcSEcCtD
Fluticasone Propionate—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	3.12e-05	0.00368	CbGpPWpGaD
Fluticasone Propionate—Headache—Formoterol—chronic obstructive pulmonary disease	3.11e-05	0.000621	CcSEcCtD
Fluticasone Propionate—Headache—Arformoterol—chronic obstructive pulmonary disease	3.11e-05	0.000621	CcSEcCtD
Fluticasone Propionate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	3.11e-05	0.00062	CcSEcCtD
Fluticasone Propionate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	3.1e-05	0.000619	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.000619	CcSEcCtD
Fluticasone Propionate—Vomiting—Montelukast—chronic obstructive pulmonary disease	3.1e-05	0.000617	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	3.09e-05	0.00365	CbGpPWpGaD
Fluticasone Propionate—Rash—Montelukast—chronic obstructive pulmonary disease	3.07e-05	0.000612	CcSEcCtD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.00362	CbGpPWpGaD
Fluticasone Propionate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	3.07e-05	0.000611	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	3.06e-05	0.00061	CcSEcCtD
Fluticasone Propionate—Headache—Montelukast—chronic obstructive pulmonary disease	3.05e-05	0.000608	CcSEcCtD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.00359	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	3.03e-05	0.00357	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.03e-05	0.00357	CbGpPWpGaD
Fluticasone Propionate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	3.01e-05	0.000601	CcSEcCtD
Fluticasone Propionate—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.00354	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3e-05	0.00354	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	2.99e-05	0.00352	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	2.98e-05	0.000595	CcSEcCtD
Fluticasone Propionate—Malaise—Prednisolone—chronic obstructive pulmonary disease	2.97e-05	0.000593	CcSEcCtD
Fluticasone Propionate—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.97e-05	0.0035	CbGpPWpGaD
Fluticasone Propionate—Rash—Salbutamol—chronic obstructive pulmonary disease	2.96e-05	0.00059	CcSEcCtD
Fluticasone Propionate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	2.96e-05	0.000589	CcSEcCtD
Fluticasone Propionate—Nausea—Formoterol—chronic obstructive pulmonary disease	2.95e-05	0.000589	CcSEcCtD
Fluticasone Propionate—Nausea—Arformoterol—chronic obstructive pulmonary disease	2.95e-05	0.000589	CcSEcCtD
Fluticasone Propionate—Headache—Salbutamol—chronic obstructive pulmonary disease	2.94e-05	0.000586	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	2.92e-05	0.00345	CbGpPWpGaD
Fluticasone Propionate—Nausea—Montelukast—chronic obstructive pulmonary disease	2.89e-05	0.000576	CcSEcCtD
Fluticasone Propionate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	2.85e-05	0.000568	CcSEcCtD
Fluticasone Propionate—Nausea—Salbutamol—chronic obstructive pulmonary disease	2.79e-05	0.000556	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	2.77e-05	0.000553	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	2.71e-05	0.000539	CcSEcCtD
Fluticasone Propionate—Oedema—Prednisolone—chronic obstructive pulmonary disease	2.69e-05	0.000537	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	2.69e-05	0.000537	CcSEcCtD
Fluticasone Propionate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	2.63e-05	0.000524	CcSEcCtD
Fluticasone Propionate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	2.57e-05	0.000513	CcSEcCtD
Fluticasone Propionate—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.49e-05	0.00294	CbGpPWpGaD
Fluticasone Propionate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000496	CcSEcCtD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.00291	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.0029	CbGpPWpGaD
Fluticasone Propionate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	2.46e-05	0.00049	CcSEcCtD
Fluticasone Propionate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	2.41e-05	0.000481	CcSEcCtD
Fluticasone Propionate—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	2.41e-05	0.00284	CbGpPWpGaD
Fluticasone Propionate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	2.4e-05	0.000478	CcSEcCtD
Fluticasone Propionate—Erythema—Prednisone—chronic obstructive pulmonary disease	2.4e-05	0.000478	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	2.36e-05	0.00278	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.34e-05	0.00276	CbGpPWpGaD
Fluticasone Propionate—Pain—Prednisolone—chronic obstructive pulmonary disease	2.3e-05	0.000459	CcSEcCtD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	2.29e-05	0.0027	CbGpPWpGaD
Fluticasone Propionate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	2.26e-05	0.00045	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000443	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	2.22e-05	0.000442	CcSEcCtD
Fluticasone Propionate—Agitation—Prednisone—chronic obstructive pulmonary disease	2.2e-05	0.000439	CcSEcCtD
Fluticasone Propionate—Angioedema—Prednisone—chronic obstructive pulmonary disease	2.19e-05	0.000437	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	2.18e-05	0.00257	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	2.17e-05	0.00256	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.17e-05	0.00256	CbGpPWpGaD
Fluticasone Propionate—Malaise—Prednisone—chronic obstructive pulmonary disease	2.16e-05	0.000431	CcSEcCtD
Fluticasone Propionate—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.14e-05	0.00253	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	2.14e-05	0.000426	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	2.1e-05	0.00248	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APIP—chronic obstructive pulmonary disease	2.09e-05	0.00247	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.08e-05	0.00246	CbGpPWpGaD
Fluticasone Propionate—Hypertension—Prednisone—chronic obstructive pulmonary disease	2.07e-05	0.000413	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.00242	CbGpPWpGaD
Fluticasone Propionate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	2.04e-05	0.000407	CcSEcCtD
Fluticasone Propionate—Anxiety—Prednisone—chronic obstructive pulmonary disease	2.03e-05	0.000405	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	2.03e-05	0.000404	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisone—chronic obstructive pulmonary disease	2.02e-05	0.000402	CcSEcCtD
Fluticasone Propionate—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	2e-05	0.00236	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	1.99e-05	0.00235	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	1.98e-05	0.000395	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.97e-05	0.00233	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	1.96e-05	0.00232	CbGpPWpGaD
Fluticasone Propionate—Oedema—Prednisone—chronic obstructive pulmonary disease	1.96e-05	0.00039	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	1.96e-05	0.00039	CcSEcCtD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.95e-05	0.0023	CbGpPWpGaD
Fluticasone Propionate—Infection—Prednisone—chronic obstructive pulmonary disease	1.94e-05	0.000387	CcSEcCtD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.00227	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.92e-05	0.00227	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	1.92e-05	0.000382	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.91e-05	0.00226	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.00226	CbGpPWpGaD
Fluticasone Propionate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	1.91e-05	0.000381	CcSEcCtD
Fluticasone Propionate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	1.9e-05	0.000379	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.00223	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.86e-05	0.00219	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.00214	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.00211	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	1.78e-05	0.000355	CcSEcCtD
Fluticasone Propionate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	1.78e-05	0.000355	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.0021	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.75e-05	0.00206	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.00203	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	1.7e-05	0.00201	CbGpPWpGaD
Fluticasone Propionate—Rash—Prednisolone—chronic obstructive pulmonary disease	1.7e-05	0.000338	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	1.7e-05	0.000338	CcSEcCtD
Fluticasone Propionate—Headache—Prednisolone—chronic obstructive pulmonary disease	1.69e-05	0.000336	CcSEcCtD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.66e-05	0.00196	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.63e-05	0.00192	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.62e-05	0.00192	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	1.61e-05	0.000321	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.6e-05	0.00189	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	1.6e-05	0.000319	CcSEcCtD
Fluticasone Propionate—Nausea—Prednisolone—chronic obstructive pulmonary disease	1.6e-05	0.000319	CcSEcCtD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.00186	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.57e-05	0.00185	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Prednisone—chronic obstructive pulmonary disease	1.55e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	1.55e-05	0.000308	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	1.55e-05	0.000308	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.53e-05	0.0018	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.5e-05	0.00178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.00176	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.49e-05	0.00175	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.00175	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	1.48e-05	0.00175	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	1.46e-05	0.00172	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.45e-05	0.00171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	1.45e-05	0.00171	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	1.44e-05	0.000287	CcSEcCtD
Fluticasone Propionate—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.00167	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.41e-05	0.00167	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.00165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.39e-05	0.00164	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Prednisone—chronic obstructive pulmonary disease	1.38e-05	0.000276	CcSEcCtD
Fluticasone Propionate—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.38e-05	0.00163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.38e-05	0.00163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.37e-05	0.00162	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.00161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GC—chronic obstructive pulmonary disease	1.35e-05	0.00159	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	1.34e-05	0.000267	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.34e-05	0.00158	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.00155	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.29e-05	0.000258	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.00153	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.00148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.25e-05	0.00148	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.24e-05	0.000248	CcSEcCtD
Fluticasone Propionate—Rash—Prednisone—chronic obstructive pulmonary disease	1.23e-05	0.000246	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.23e-05	0.000246	CcSEcCtD
Fluticasone Propionate—Headache—Prednisone—chronic obstructive pulmonary disease	1.23e-05	0.000244	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	1.22e-05	0.00144	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.2e-05	0.00141	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	1.18e-05	0.00139	CbGpPWpGaD
Fluticasone Propionate—Nausea—Prednisone—chronic obstructive pulmonary disease	1.16e-05	0.000232	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.16e-05	0.00137	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.15e-05	0.00135	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.00135	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	1.14e-05	0.00134	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.12e-05	0.00132	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.1e-05	0.0013	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	1.08e-05	0.00127	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.08e-05	0.00127	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	1.05e-05	0.00124	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.05e-05	0.00123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.03e-05	0.00121	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.01e-05	0.00119	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.01e-05	0.00119	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.99e-06	0.00118	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.97e-06	0.00118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	9.97e-06	0.00118	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	9.91e-06	0.00117	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	9.9e-06	0.00117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MMP1—chronic obstructive pulmonary disease	9.84e-06	0.00116	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	9.75e-06	0.00115	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.66e-06	0.00114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PLAU—chronic obstructive pulmonary disease	9.66e-06	0.00114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.6e-06	0.00113	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	9.4e-06	0.00111	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.32e-06	0.0011	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	9.24e-06	0.00109	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	9.15e-06	0.00108	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS2—chronic obstructive pulmonary disease	8.87e-06	0.00105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.78e-06	0.00104	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.74e-06	0.00103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.67e-06	0.00102	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.47e-06	0.000999	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.38e-06	0.000989	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.27e-06	0.000976	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.99e-06	0.000943	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	7.83e-06	0.000924	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.52e-06	0.000887	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	7.47e-06	0.000882	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	7.46e-06	0.00088	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—ALB—chronic obstructive pulmonary disease	7.46e-06	0.00088	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.37e-06	0.000869	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GCLC—chronic obstructive pulmonary disease	7.28e-06	0.000859	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS3—chronic obstructive pulmonary disease	7.13e-06	0.000842	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.08e-06	0.000836	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.99e-06	0.000825	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.98e-06	0.000824	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.9e-06	0.000814	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	6.79e-06	0.000802	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.79e-06	0.000801	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.72e-06	0.000793	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CTGF—chronic obstructive pulmonary disease	6.64e-06	0.000784	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.45e-06	0.000761	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.43e-06	0.000758	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.34e-06	0.000748	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.34e-06	0.000748	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.32e-06	0.000745	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.12e-06	0.000722	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.09e-06	0.000719	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.05e-06	0.000714	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.01e-06	0.000709	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.89e-06	0.000695	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.88e-06	0.000694	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.73e-06	0.000676	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.63e-06	0.000665	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.44e-06	0.000642	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.18e-06	0.000611	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.14e-06	0.000607	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.13e-06	0.000606	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.11e-06	0.000603	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	5.07e-06	0.000599	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.04e-06	0.000594	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.9e-06	0.000578	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.86e-06	0.000573	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.81e-06	0.000568	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.77e-06	0.000563	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.72e-06	0.000557	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.69e-06	0.000554	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	4.63e-06	0.000546	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.45e-06	0.000525	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.44e-06	0.000524	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.42e-06	0.000521	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.27e-06	0.000503	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.25e-06	0.000502	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.97e-06	0.000468	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.95e-06	0.000466	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—chronic obstructive pulmonary disease	3.88e-06	0.000458	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.71e-06	0.000438	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.67e-06	0.000433	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.63e-06	0.000429	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.61e-06	0.000426	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.56e-06	0.00042	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.51e-06	0.000414	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.47e-06	0.00041	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.35e-06	0.000395	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.27e-06	0.000386	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.25e-06	0.000383	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.23e-06	0.000381	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.16e-06	0.000373	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.1e-06	0.000366	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.1e-06	0.000366	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.08e-06	0.000364	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—chronic obstructive pulmonary disease	3.02e-06	0.000357	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.96e-06	0.000349	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.94e-06	0.000346	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.89e-06	0.000341	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.76e-06	0.000325	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.65e-06	0.000313	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.63e-06	0.00031	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.57e-06	0.000304	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.54e-06	0.000299	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.53e-06	0.000299	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.42e-06	0.000285	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.38e-06	0.00028	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.36e-06	0.000279	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.24e-06	0.000264	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.15e-06	0.000253	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.13e-06	0.000252	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	2.11e-06	0.000249	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.04e-06	0.000241	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	2.02e-06	0.000238	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.96e-06	0.000231	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.94e-06	0.000229	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.92e-06	0.000227	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.74e-06	0.000206	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-06	0.000204	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-06	0.000201	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.61e-06	0.00019	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.6e-06	0.000189	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.57e-06	0.000185	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-06	0.000184	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.52e-06	0.00018	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.48e-06	0.000174	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.46e-06	0.000172	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-06	0.000169	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.32e-06	0.000155	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.21e-06	0.000142	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-06	0.000141	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-06	0.000139	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-06	0.00013	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.08e-07	8.36e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.77e-07	7.99e-05	CbGpPWpGaD
